STRIVE at HIVR4P 2018

18 October 2018
Sephy Valuks

Find out more about STRIVE sessions at the HIV Research for Prevention Conference.

 

An expected 1,500 leaders in HIV prevention research, programming and policy will gather in Madrid from 21-25 October for the HIV Research for Prevention (HIVR4P) conference. HIVR4P is the world's first and only international scientific meeting dedicated exclusively to biomedical HIV prevention research. 

Below we provide details of all the STRIVE sessions taking place over the course of the week.

Monday 22 October

Love, Power and PrEP: Addressing relationship dynamics and intimate partner violence to promote successful HIV prevention for women and girls

Satellite session, 12:00 - 15:00, Bristol Room

Chaired by: Kawango Agot (Impact Research and Development Organization), Jared Baeten (University of Washington)

No RSVP required

This satellite session highlights the critical influence of relationship dynamics on women’s and girls’ HIV risk and their use of HIV prevention methods. New evidence will be presented from adolescent girls, young women, sex workers, and male partners in Kenya, Ghana and Tanzania on their HIV prevention needs and preferences. Also, new evidence will be presented from interventions (CHARISMA, EMPOWER and Project SOAR) implemented in South Africa and Tanzania that jointly address relationship dynamics, intimate partner violence, HIV prevention, and PrEP.

Tuesday 23 October

Preventing Intimate Partner Violence Among Women in Mwanza, Tanzania: Findings from the MAISHA Trial and Implications for HIV Prevention

Shelley Lees, LSHTM, United Kingdom

Poster presentation (Behavioural and Social Science Research), Poster Hall, 17:30 - 19:30

Wednesday 24 October

Key to the response: Populations, Partners and Prevention

Oral session, 10:30 - 12:00, Bristol Room

This session includes an oral presentation with STRIVE researcher Sheila Harvey: 'Help-seeking Behavior of Women Reporting Intimate Partner Violence in Mwanza, Tanzania, and Its Implications for HIV: Findings From the MAISHA Study'  

 

“There Is Nothing to Hide”: Disclosure of PrEP Use by Young Women in South Africa and Tanzania – Findings From a Demonstration Project

Sinead Delany-Moretlwe, University of the Witwatersrand, South Africa 

Poster presentation (Behavioural and Social Science Research), Poster Hall, 17:30 - 19:30 

 

Intimate Partner Violence and Women Testing for HIV: Findings From the MAISHA Study in North-Western Tanzania

Sheila Harvey, London School of Hygiene & Tropical Medicine, United Kingdom

Poster presentation (Behavioural and Social Science Research), Poster Hall, 17:30 - 19:30 

 

Targeted Adolescent HIV Testing in Two South African Health Sub-districts

Sinead Delany-Moretlwe, University of the Witwatersrand, South Africa 

Poster presentation (Delivery Technologies: Novel approaches, Formulation and Multi-purpose), Poster Hall, 17:30 - 19:30 

 

Thursday 25 October 

Choosing to use: What People Want from HIV Prevention

Symposium, 13:00 - 14:30, Bristol Room

Chaired by: Sinead Delany-Moretlwe and Andrew Mujugira 

HIV prevention products currently in use were introduced after successful clinical trials for efficacy with little consideration of user preference. Results from completed efficacy trials consistently show evidence of low product use among adolescent and young women. This session will explore strategies for adherence support, risk perception, social marketing and end-user engagement strategies during product development.

In addition we recommend the following satellite session taking place on Monday 22 October.

VOICES in the long-acting PrEP Movement: what do end-users have to say to developers and how are their voices heard?

Satellite session, 8:30-11:30, Burdeos Room
Chaired by: Linda-Gail Bekker, DTHF, and Mitchell Warren, AVAC
RSVP to: iPreventatrti.org

This satellite session aims to demonstrate and discuss strategies to foster open and iterative dialog between end-users and product developers of long-acting HIV prevention products. The involvement of end-user voices during earlier stages of product development to pre-emptively identify and address product attributes that may introduce challenges to their acceptability, uptake, and consistent use is critical. The session will share innovative methodologies used by behavioral researchers and marketing specialists to capture end-user feedback, hear from product developers and pharmaceutical companies as to how they’re using this feedback, and discuss ways to continue to enhance this dialog.